Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Piccart

Showing results (91-100 of 186) with videos related to

Pageof 19
Sort By:
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Phase II trial of mitozolomide in patients with advanced ovarian cancer. A study of the EORTC Gynecological Cancer Cooperative GroupJ P Neijt, M E van der Burg, J P Guastalla, et al.
Transplantation Proceedings|April 1, 1995
Inadvertent transfer of choriocarcinoma with renal transplantation: characteristics of the donor-recipient pairsJ M Doutrelepont, O Mat, D Abramowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolamD Razavi, N Delvaux, C Farvacques, et al.
International Journal of Cancer|June 17, 1999
Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcomeL Lespagnard, D Gancberg, G Rouas, et al.
American Journal of Clinical Pathology|May 9, 2000
Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas. Correlation with oncogene amplification in 160 casesD Gancberg, L Lespagnard, G Rouas, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2006
A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993)R E Coleman, L Biganzoli, P Canney, et al.
European Journal of Cancer (Oxford, England : 1990)|April 22, 1999
Florence statement on breast cancer, 1998 forging the way ahead for more research on and better care in breast cancerL Cataliotti, A Costa, P A Daly, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1988
Phase I clinical and pharmacokinetic trial of oral menogaril administered on three consecutive daysP Dodion, D de Valeriola, N Crespeigne, et al.
Oncology Reports|September 18, 2004
Gene regulation by phorbol 12-myristate 13-acetate in MCF-7 and MDA-MB-231, two breast cancer cell lines exhibiting highly different phenotypesM Lacroix, B Haibe-Kains, B Hennuy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials GroupG Catimel, J Verweij, V Mattijssen, et al.
Pageof 19

Showing results (91-100 of 186) with videos related to

Sort By:
Pageof 19
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Phase II trial of mitozolomide in patients with advanced ovarian cancer. A study of the EORTC Gynecological Cancer Cooperative GroupJ P Neijt, M E van der Burg, J P Guastalla, et al.
Transplantation Proceedings|April 1, 1995
Inadvertent transfer of choriocarcinoma with renal transplantation: characteristics of the donor-recipient pairsJ M Doutrelepont, O Mat, D Abramowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolamD Razavi, N Delvaux, C Farvacques, et al.
International Journal of Cancer|June 17, 1999
Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcomeL Lespagnard, D Gancberg, G Rouas, et al.
American Journal of Clinical Pathology|May 9, 2000
Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas. Correlation with oncogene amplification in 160 casesD Gancberg, L Lespagnard, G Rouas, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2006
A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993)R E Coleman, L Biganzoli, P Canney, et al.
European Journal of Cancer (Oxford, England : 1990)|April 22, 1999
Florence statement on breast cancer, 1998 forging the way ahead for more research on and better care in breast cancerL Cataliotti, A Costa, P A Daly, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1988
Phase I clinical and pharmacokinetic trial of oral menogaril administered on three consecutive daysP Dodion, D de Valeriola, N Crespeigne, et al.
Oncology Reports|September 18, 2004
Gene regulation by phorbol 12-myristate 13-acetate in MCF-7 and MDA-MB-231, two breast cancer cell lines exhibiting highly different phenotypesM Lacroix, B Haibe-Kains, B Hennuy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials GroupG Catimel, J Verweij, V Mattijssen, et al.
Pageof 19